James J Urbanic - JoVE Visualize

Showing results (31-40 of 48) with videos related to

Pageof 5

Sort By:

Journal of Neurosurgery|December 21, 2010

Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasisCourtney A Jensen, Michael D Chan, Thomas P McCoy, et al.

Journal of Neuro-Oncology|February 8, 2014

Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?Jeremy M Kilburn, Thomas L Ellis, James F Lovato, et al.

International Journal of Radiation Oncology, Biology, Physics|May 24, 2011

Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular diseases or multiple sclerosisDot Lowell, Stephen B Tatter, J Daniel Bourland, et al.

Journal of Neuro-Oncology|September 25, 2012

Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgeryTamara Z Vern-Gross, Julia A Lawrence, L Douglas Case, et al.

Clinical Breast Cancer|October 10, 2022

Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical TrialRyan T Hughes, Edward H Ip, James J Urbanic, et al.

Journal of Medical Imaging and Radiation Oncology|October 10, 2012

Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0 T versus 1.5 T MRI-based treatment planning: have we finally optimised detection of occult brain metastases?Amritraj G Loganathan, Michael D Chan, Natalie Alphonse, et al.

International Journal of Radiation Oncology, Biology, Physics|November 24, 2023

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical TrialGilmer Valdes, Jessica Scholey, Tomi F Nano, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018

Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer PopulationJennifer J Hu, James J Urbanic, L Doug Case, et al.

Clinical and Translational Radiation Oncology|May 28, 2026

Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancerAnna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.

The Lancet. Oncology|July 9, 2017

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialPaul D Brown, Karla V Ballman, Jane H Cerhan, et al.

Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:

Pageof 5

Journal of Neurosurgery|December 21, 2010

Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasisCourtney A Jensen, Michael D Chan, Thomas P McCoy, et al.

Journal of Neuro-Oncology|February 8, 2014

Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?Jeremy M Kilburn, Thomas L Ellis, James F Lovato, et al.

International Journal of Radiation Oncology, Biology, Physics|May 24, 2011

Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular diseases or multiple sclerosisDot Lowell, Stephen B Tatter, J Daniel Bourland, et al.

Journal of Neuro-Oncology|September 25, 2012

Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgeryTamara Z Vern-Gross, Julia A Lawrence, L Douglas Case, et al.

Clinical Breast Cancer|October 10, 2022

Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical TrialRyan T Hughes, Edward H Ip, James J Urbanic, et al.

Journal of Medical Imaging and Radiation Oncology|October 10, 2012

Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0 T versus 1.5 T MRI-based treatment planning: have we finally optimised detection of occult brain metastases?Amritraj G Loganathan, Michael D Chan, Natalie Alphonse, et al.

International Journal of Radiation Oncology, Biology, Physics|November 24, 2023

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical TrialGilmer Valdes, Jessica Scholey, Tomi F Nano, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018

Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer PopulationJennifer J Hu, James J Urbanic, L Doug Case, et al.

Clinical and Translational Radiation Oncology|May 28, 2026

Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancerAnna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.

The Lancet. Oncology|July 9, 2017

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialPaul D Brown, Karla V Ballman, Jane H Cerhan, et al.

Pageof 5